Stefan Heller

Stefan Heller is the Edward C. and Amy H. Sewall Professor in the School of Medicine at Stanford University. He has served as Director of Research and then Vice-Chair of Research in the Research Division of the Department of Otolaryngology-Head and Neck Surgery. He is also a primary faculty member of the Stanford Institute for Stem Cell Biology and Regenerative Medicine. Dr. Heller’s research is focused on regenerative medicine in the inner ear. He employs molecular and single-cell transcriptomic methods and he works on developing stem cell-based cellular drug screening assays. Dr. Heller has served as an advisor for Otonomy, an Avalon Ventures company, and he is currently a scientific advisor for Pipeline Therapeutics. Dr. Heller currently serves as a board member for Janux Therapeutics, Adanate, Inc., Fortis Therapeutics, Inc., and Nerio Therapeutics. Prior to joining Stanford University, Dr. Heller was a faculty member at Harvard Medical School. He held a postdoctoral position at The Rockefeller University and obtained his Ph.D. in Genetics from Johannes Gutenberg University in Mainz.